Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07032818 · ClinicalTrials.gov registry record · NA
Adapted Hospital Discharge Intervention: the CONNECT Pilot
A NA study of Communication Research, sponsored by Boston Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07032818: Recruiting NA study of Communication Research, sponsored by Boston Medical Center.
NCT07032818 is a NA study of Communication Research that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 60 participants, below the 494-participant average among 6 other Communication Research trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07032818, a NA study of Communication Research, is actively recruiting participants, sponsored by Boston Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Hospital discharge is a dangerous time for patients: one in five will suffer an adverse event, such as a medication error, and nearly 25% will be readmitted within 30 days. This time is even more dangerous for patients with who face communication barriers, including those with non-English language preference (NELP), low health literacy, and the elderly. The investigators will pilot a post-discharge educational intervention to reinforce written discharge instructions (known as the After Visit Summary or AVS) using a randomized controlled trial design (2:1 intervention: control). The control group will receive current standard of care discharge education which includes a nurse reviewing their AVS and an automated call in English that allows patients to numerically select types of problems/questions that are then escalated to a nurse who should return their call within a few days. The intervention group will receive the standard of care discharge education with the AVS and an additional post-discharge educational call delivered by a registered nurse or other qualified health professional with the option to have written instructions professionally translated and sent via MyChart message--if available in their preferred language.
Primary Outcome
Number of enrolled participants who completed all study assessments stratified by linguistic group.
Conditions Studied
Interventions
- OTHER Additional post discharge phone call
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-01-16 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT07032818 shows while recruiting
NCT07032818 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 494-participant average among 6 other Communication Research trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Communication Research appearing as the primary indexed condition, and to 1 intervention - of which Additional post discharge phone call is the first listed.
NCT07032818 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07032818 about?
NCT07032818 is a clinical study titled "Adapted Hospital Discharge Intervention: the CONNECT Pilot". Hospital discharge is a dangerous time for patients: one in five will suffer an adverse event, such as a medication error, and nearly 25% will be readmitted within 30 days. This time is even more dangerous for patients with who face communication barriers, including those with non-English language p...
What is the current status of trial NCT07032818?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-01-16. Estimated completion is 2027-03.
What conditions does trial NCT07032818 study?
This clinical trial studies the following conditions: Communication Research.
What interventions are being tested in trial NCT07032818?
The interventions under investigation include: Additional post discharge phone call (OTHER).
Who is sponsoring clinical trial NCT07032818?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07032818 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Communication Research
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Mastery Learning in Communication Skills
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
Writing Intervention With Adolescents and Young Adults With Cancer
RECRUITING · NA
-
Measuring and Displaying the Subjective
COMPLETED · NA
-
Advance Care Planning GuideTailored for Primary Care Patients
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI